DK0946547T3 - Hidtil ukendt forbindelsesform - Google Patents
Hidtil ukendt forbindelsesformInfo
- Publication number
- DK0946547T3 DK0946547T3 DK97951367T DK97951367T DK0946547T3 DK 0946547 T3 DK0946547 T3 DK 0946547T3 DK 97951367 T DK97951367 T DK 97951367T DK 97951367 T DK97951367 T DK 97951367T DK 0946547 T3 DK0946547 T3 DK 0946547T3
- Authority
- DK
- Denmark
- Prior art keywords
- connection
- hitherto unknown
- unknown form
- hitherto
- unknown
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9604793A SE510666C2 (sv) | 1996-12-20 | 1996-12-20 | Nya Kristallmodifikationer |
PCT/SE1997/002125 WO1998028294A1 (en) | 1996-12-20 | 1997-12-16 | A novel compound form |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0946547T3 true DK0946547T3 (da) | 2003-06-30 |
Family
ID=20405146
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK97951367T DK0946547T3 (da) | 1996-12-20 | 1997-12-16 | Hidtil ukendt forbindelsesform |
Country Status (37)
Country | Link |
---|---|
US (1) | US6162816A (da) |
EP (1) | EP0946547B1 (da) |
JP (1) | JP4402174B2 (da) |
KR (1) | KR20000069595A (da) |
CN (1) | CN1109684C (da) |
AR (1) | AR010361A1 (da) |
AT (1) | ATE236898T1 (da) |
AU (1) | AU730129B2 (da) |
BR (1) | BR9714059A (da) |
CA (1) | CA2274076C (da) |
CZ (1) | CZ294784B6 (da) |
DE (1) | DE69720774T2 (da) |
DK (1) | DK0946547T3 (da) |
EE (1) | EE03923B1 (da) |
EG (1) | EG24414A (da) |
ES (1) | ES2194231T3 (da) |
HK (1) | HK1022909A1 (da) |
HU (1) | HU227589B1 (da) |
ID (1) | ID21850A (da) |
IL (1) | IL130450A0 (da) |
IS (1) | IS1981B (da) |
MY (1) | MY117032A (da) |
NO (1) | NO317191B1 (da) |
NZ (1) | NZ336024A (da) |
PL (1) | PL190377B1 (da) |
PT (1) | PT946547E (da) |
RS (1) | RS49685B (da) |
RU (1) | RU2184734C2 (da) |
SA (1) | SA97180739B1 (da) |
SE (1) | SE510666C2 (da) |
SI (1) | SI0946547T1 (da) |
SK (1) | SK285151B6 (da) |
TR (1) | TR199901410T2 (da) |
TW (1) | TW538039B (da) |
UA (1) | UA55436C2 (da) |
WO (1) | WO1998028294A1 (da) |
ZA (1) | ZA9711046B (da) |
Families Citing this family (60)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6489346B1 (en) | 1996-01-04 | 2002-12-03 | The Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and method of using same |
US6645988B2 (en) | 1996-01-04 | 2003-11-11 | Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and method of using same |
US5840737A (en) | 1996-01-04 | 1998-11-24 | The Curators Of The University Of Missouri | Omeprazole solution and method for using same |
US6699885B2 (en) | 1996-01-04 | 2004-03-02 | The Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and methods of using same |
SI20019A (sl) | 1998-07-13 | 2000-02-29 | LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. | Izboljšan postopek sinteze 5-metoksi -2-/(4-metoksi-3,5-dimetil-2-piridil)metil/ sulfinil-1H-benzimidazola |
IL142703A (en) | 1998-11-10 | 2006-04-10 | Astrazeneca Ab | Crystalline form of omeprazole |
UA72748C2 (en) * | 1998-11-10 | 2005-04-15 | Astrazeneca Ab | A novel crystalline form of omeprazole |
JP3926936B2 (ja) * | 1998-11-16 | 2007-06-06 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | スルホキシド誘導体・アセトン錯体およびその製造法 |
SE9804003D0 (sv) * | 1998-11-23 | 1998-11-23 | Astra Ab | A method of producing drug particles |
SE9900274D0 (sv) | 1999-01-28 | 1999-01-28 | Astra Ab | New compound |
JP2000344739A (ja) * | 1999-06-01 | 2000-12-12 | Sumitomo Chem Co Ltd | N−保護−アゼチジン−2−カルボン酸の製造方法 |
TWI275587B (en) | 1999-06-17 | 2007-03-11 | Takeda Chemical Industries Ltd | A crystal of (R)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methyl]sulfinyl]-1H-benzimidazole |
SE0000773D0 (sv) * | 2000-03-08 | 2000-03-08 | Astrazeneca Ab | New formulation |
SE0000774D0 (sv) | 2000-03-08 | 2000-03-08 | Astrazeneca Ab | New formulation |
ES2511774T3 (es) | 2000-05-15 | 2014-10-23 | Takeda Pharmaceutical Company Limited | Formas cristalinas de (R)-lansoprazol |
GB0016040D0 (en) * | 2000-06-29 | 2000-08-23 | Glaxo Group Ltd | Novel process for preparing crystalline particles |
CA2775616C (en) | 2000-08-04 | 2013-09-17 | Takeda Pharmaceutical Company Limited | Salts of benzimidazole compound and application thereof |
SI20875A (sl) * | 2001-04-25 | 2002-10-31 | LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. | Kristalna oblika omeprazola |
US8206741B2 (en) | 2001-06-01 | 2012-06-26 | Pozen Inc. | Pharmaceutical compositions for the coordinated delivery of NSAIDs |
WO2002098352A2 (en) | 2001-06-01 | 2002-12-12 | Pozen Inc. | PHARMACEUTICAL COMPOSITIONS FOR THE COORDINATED DELIVERY OF NSAIDs |
GB2376231A (en) | 2001-06-06 | 2002-12-11 | Cipla Ltd | Benzimidazole-cyclodextrin inclusion complex |
SE0102993D0 (sv) | 2001-09-07 | 2001-09-07 | Astrazeneca Ab | New self emulsifying drug delivery system |
WO2004002982A2 (en) * | 2002-06-27 | 2004-01-08 | Dr. Reddy's Laboratories Limited | A process for preparation of optically pure or optically enriched sulfoxide compounds, including amorphous esomeprazole and salts thereof |
DE60311809T2 (de) * | 2002-06-27 | 2007-11-22 | Dr. Reddy's Laboratories Ltd. | Verfahren zur herstellung optisch reiner oder optisch angereicherter sulfoxidverbindungen einschliesslich amorphen esomeprazols und dessen salze |
WO2004020436A1 (en) * | 2002-08-30 | 2004-03-11 | Reddy's Laboratories Limited | Amorphous hydrates of esomeprazole magnesium and process for the preparation thereof |
AU2003273000A1 (en) | 2002-10-16 | 2004-05-04 | Takeda Pharmaceutical Company Limited | Stable solid preparations |
EA200500673A1 (ru) * | 2002-10-22 | 2005-12-29 | Рэнбакси Лабораториз Лимитед | Аморфная форма соли эзомепразола, способ ее получения и фармацевтическая композиция на её основе |
WO2004046134A2 (en) * | 2002-11-18 | 2004-06-03 | Dr. Reddy's Laboratories Limited | Crystalline form ii of esomeprazole magnesium trihydrate and process for its preparation |
CN1777598A (zh) * | 2003-02-28 | 2006-05-24 | 兰贝克赛实验室有限公司 | S-奥美拉唑的多晶型物 |
CN100364987C (zh) * | 2003-03-24 | 2008-01-30 | 卫材R&D管理有限公司 | 亚砜衍生物或其盐的非定形态的制备方法 |
CN1842525A (zh) * | 2003-05-05 | 2006-10-04 | 兰贝克赛实验室有限公司 | 苯并咪唑衍生物的钡盐 |
US8993599B2 (en) | 2003-07-18 | 2015-03-31 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
SE0400410D0 (sv) | 2004-02-20 | 2004-02-20 | Astrazeneca Ab | New compounds |
US8815916B2 (en) | 2004-05-25 | 2014-08-26 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
US8906940B2 (en) | 2004-05-25 | 2014-12-09 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
CA2570916C (en) | 2004-06-16 | 2013-06-11 | Tap Pharmaceutical Products, Inc. | Pulsed release dosage form of a ppi |
WO2006001753A1 (en) * | 2004-06-24 | 2006-01-05 | Astrazeneca Ab | New process for the preparation of crystal modifications for use in the preparation of esomeprazole sodium salt |
ES2246149B1 (es) * | 2004-07-02 | 2007-06-01 | Esteve Quimica, S.A. | Formas solidas de la sal magnesica de s-omeprazol y procedimientos para su preparacion. |
EP1885711A1 (en) * | 2005-05-06 | 2008-02-13 | Glenmark Pharmaceuticals Limited | Esomeprazole strontium salt, process for its preparation and pharmaceutical compositions containing same |
EP1907375B1 (en) * | 2005-06-08 | 2013-07-24 | LEK Pharmaceuticals d.d. | Crystalline solvate of omeprazole sodium |
WO2006134605A1 (en) * | 2005-06-15 | 2006-12-21 | Hetero Drugs Limited | Amorphous esomeprazole hydrate |
NL2000126C2 (nl) * | 2005-07-15 | 2008-01-29 | Solvay | Werkwijze voor de vervaardiging van eptifibatide. |
US20070043085A1 (en) * | 2005-08-19 | 2007-02-22 | Glenmark Pharmaceuticals Limited | Process for the preparation of amorphous form of neutral esomeprazole |
US7576219B2 (en) | 2005-10-26 | 2009-08-18 | Hanmi Pharm. Co., Ltd | Crystalline S-omeprazole strontium hydrate, method for preparing same, and pharmaceutical composition containing same |
WO2007054951A1 (en) * | 2005-11-14 | 2007-05-18 | Hetero Drugs Limited | Process for amorphous esomeprazole |
AU2006323245B2 (en) * | 2005-12-05 | 2011-03-03 | Astrazeneca Ab | New process for the preparation of esomeprazole non-salt form |
EP1801110A1 (en) | 2005-12-22 | 2007-06-27 | KRKA, tovarna zdravil, d.d., Novo mesto | Esomeprazole arginine salt |
US7799925B2 (en) | 2005-12-28 | 2010-09-21 | Unión Químico Farmacéutica, S.A. | Process for the preparation of the (S)-enantiomer of omeprazole |
EP2000468A1 (en) * | 2007-05-09 | 2008-12-10 | Dr. Reddy's Laboratories Ltd. | Esomeprazole salts and processes for preparation thereof |
US8106210B2 (en) | 2007-10-08 | 2012-01-31 | Hetero Drugs Limited | Polymorphs of esomeprazole salts |
JP2011513202A (ja) | 2008-03-10 | 2011-04-28 | 武田薬品工業株式会社 | ベンズイミダゾール化合物の結晶 |
EP2143722A1 (en) | 2008-07-09 | 2010-01-13 | Lek Pharmaceuticals D.D. | Process for preparation of esomeprazole sodium of high chemical purity and new forms of esomeprazole sodium |
CA2736547C (en) * | 2008-09-09 | 2016-11-01 | Pozen Inc. | Method for delivering a pharmaceutical composition to patient in need thereof |
AU2010263304A1 (en) | 2009-06-25 | 2012-02-02 | Astrazeneca Ab | Method for treating a patient at risk for developing an NSAID-associated ulcer |
SI2510089T1 (sl) | 2009-12-08 | 2015-12-31 | Codexis, Inc. | Sinteza prazolnih spojin |
HUE037616T2 (hu) | 2010-12-08 | 2018-09-28 | Codexis Inc | Biokatalizátorok és eljárások armodafinil szintéziséhez |
MX2014007935A (es) | 2011-12-28 | 2014-11-14 | Pozen Inc | Composiciones y metodos mejorados para el suministro de omeprazol y de acido acetilsalicilico. |
RU2501549C1 (ru) | 2012-08-30 | 2013-12-20 | Авва Девелопмент Лтд | Фармацевтическая композиция для лечения гастроэзофагеальной рефлюксной болезни |
CN107043367A (zh) * | 2017-05-26 | 2017-08-15 | 重庆莱美隆宇药业有限公司 | 一种中性s‑奥美拉唑的干燥工艺 |
WO2024075017A1 (en) | 2022-10-04 | 2024-04-11 | Zabirnyk Arsenii | Inhibition of aortic valve calcification |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE7804231L (sv) * | 1978-04-14 | 1979-10-15 | Haessle Ab | Magsyrasekretionsmedel |
SE8301182D0 (sv) * | 1983-03-04 | 1983-03-04 | Haessle Ab | Novel compounds |
GB2189698A (en) * | 1986-04-30 | 1987-11-04 | Haessle Ab | Coated omeprazole tablets |
DE4035455A1 (de) * | 1990-11-08 | 1992-05-14 | Byk Gulden Lomberg Chem Fab | Enantiomerentrennung |
SE9301830D0 (sv) * | 1993-05-28 | 1993-05-28 | Ab Astra | New compounds |
US5877192A (en) * | 1993-05-28 | 1999-03-02 | Astra Aktiebolag | Method for the treatment of gastric acid-related diseases and production of medication using (-) enantiomer of omeprazole |
SE9302396D0 (sv) * | 1993-07-09 | 1993-07-09 | Ab Astra | A novel compound form |
EP0723436B1 (en) * | 1994-07-08 | 2001-09-26 | AstraZeneca AB | Multiple unit tableted dosage form i |
-
1996
- 1996-12-20 SE SE9604793A patent/SE510666C2/sv unknown
-
1997
- 1997-12-08 TW TW086118449A patent/TW538039B/zh not_active IP Right Cessation
- 1997-12-09 ZA ZA9711046A patent/ZA9711046B/xx unknown
- 1997-12-16 JP JP52868598A patent/JP4402174B2/ja not_active Expired - Fee Related
- 1997-12-16 IL IL13045097A patent/IL130450A0/xx not_active IP Right Cessation
- 1997-12-16 CN CN97180849A patent/CN1109684C/zh not_active Expired - Fee Related
- 1997-12-16 PL PL97334297A patent/PL190377B1/pl not_active IP Right Cessation
- 1997-12-16 ES ES97951367T patent/ES2194231T3/es not_active Expired - Lifetime
- 1997-12-16 SI SI9730528T patent/SI0946547T1/xx unknown
- 1997-12-16 NZ NZ336024A patent/NZ336024A/en not_active IP Right Cessation
- 1997-12-16 WO PCT/SE1997/002125 patent/WO1998028294A1/en not_active Application Discontinuation
- 1997-12-16 RU RU99116303/04A patent/RU2184734C2/ru not_active IP Right Cessation
- 1997-12-16 DE DE69720774T patent/DE69720774T2/de not_active Expired - Lifetime
- 1997-12-16 AU AU55026/98A patent/AU730129B2/en not_active Ceased
- 1997-12-16 TR TR1999/01410T patent/TR199901410T2/xx unknown
- 1997-12-16 AR ARP970105920A patent/AR010361A1/es active IP Right Grant
- 1997-12-16 KR KR1019997005574A patent/KR20000069595A/ko active Search and Examination
- 1997-12-16 SK SK765-99A patent/SK285151B6/sk not_active IP Right Cessation
- 1997-12-16 BR BR9714059-7A patent/BR9714059A/pt not_active Application Discontinuation
- 1997-12-16 US US09/000,154 patent/US6162816A/en not_active Expired - Lifetime
- 1997-12-16 ID IDW990483A patent/ID21850A/id unknown
- 1997-12-16 HU HU0001547A patent/HU227589B1/hu not_active IP Right Cessation
- 1997-12-16 PT PT97951367T patent/PT946547E/pt unknown
- 1997-12-16 AT AT97951367T patent/ATE236898T1/de active
- 1997-12-16 RS YUP-281/99A patent/RS49685B/sr unknown
- 1997-12-16 CZ CZ19992202A patent/CZ294784B6/cs not_active IP Right Cessation
- 1997-12-16 DK DK97951367T patent/DK0946547T3/da active
- 1997-12-16 EP EP97951367A patent/EP0946547B1/en not_active Expired - Lifetime
- 1997-12-16 EE EEP199900259A patent/EE03923B1/xx not_active IP Right Cessation
- 1997-12-16 CA CA002274076A patent/CA2274076C/en not_active Expired - Fee Related
- 1997-12-16 UA UA99073869A patent/UA55436C2/uk unknown
- 1997-12-19 MY MYPI97006176A patent/MY117032A/en unknown
- 1997-12-20 EG EG136097A patent/EG24414A/xx active
- 1997-12-27 SA SA97180739A patent/SA97180739B1/ar unknown
-
1999
- 1999-06-07 IS IS5070A patent/IS1981B/is unknown
- 1999-06-21 NO NO19993068A patent/NO317191B1/no not_active IP Right Cessation
-
2000
- 2000-03-31 HK HK00101986A patent/HK1022909A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0946547T3 (da) | Hidtil ukendt forbindelsesform | |
ID18406A (id) | Palang penggantung pakaian | |
CY2012029I2 (el) | Nεα μορφη της 5-ομεπραζολης | |
DE69721533D1 (de) | Bekleidungsstück | |
DE59611425D1 (de) | Messfühler | |
DE69513300D1 (de) | Bestimmungsverfahren | |
ID27092A (id) | Pembuatan ftalat anhidrida | |
DE69708751D1 (de) | Messfühler | |
DE59810721D1 (de) | Messfühler | |
PT927183E (pt) | Inibidores espirociclicos de metaloproteases | |
DK1000079T3 (da) | Hidtil ukendt formulering | |
PT829205E (pt) | Producao de condimento | |
ID28032A (id) | TRISIKLIK PIPERIDIN-Δ3-SEBAGAI ANTAGONIS-α2 | |
ID16838A (id) | Komposisi dekafluoropentana | |
ID18300A (id) | Metoda penemperan | |
ID17419A (id) | Komposisi dekafluoropentana | |
NO991148D0 (no) | Fremstilling av 1-butyl-4-piperidinyl-metylamin | |
ID22787A (id) | Nitro-benzamida berguna sebagai zat anti - arritimia | |
FR2744447B1 (fr) | Utilisation de derives de tetrahydroisoquinoleine | |
DE69733921D1 (de) | Stämme der Biefhefe | |
BR9704770A (pt) | Derivados de 1-carba-(detia)-cefalosporina | |
FI971253A (fi) | Lyoluminesenssin käyttö analyyttisiin tarkoituksiin | |
ID19538A (id) | Tempat kemeja | |
IT240519Y1 (it) | Struttura di strozzacorde | |
IT241830Y1 (it) | Struttura di portacalici |